Prostaglandin E
Animals
Dinoprost
/ pharmacology
Dinoprostone
/ pharmacology
Kidney
/ drug effects
Mice, Inbred C57BL
Prostaglandins
/ pharmacology
Receptors, Prostaglandin
/ drug effects
Receptors, Prostaglandin E, EP3 Subtype
/ drug effects
Receptors, Thromboxane
/ drug effects
Thromboxanes
/ pharmacology
Vasoconstriction
/ drug effects
Vasoconstrictor Agents
/ pharmacology
EP3
PGE2
TP
gene deficiency
renal vasoconstriction
Journal
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
29
06
2019
revised:
21
10
2019
accepted:
04
12
2019
pubmed:
8
1
2020
medline:
30
9
2020
entrez:
8
1
2020
Statut:
ppublish
Résumé
Although recognized to have an in vivo vasodepressor effect blunted by the vasoconstrictor effect of E-prostanoid receptor-3 (EP3), prostaglandin E
Identifiants
pubmed: 31908041
doi: 10.1096/fj.201901611R
doi:
Substances chimiques
Prostaglandins
0
Receptors, Prostaglandin
0
Receptors, Prostaglandin E, EP3 Subtype
0
Receptors, Thromboxane
0
Thromboxanes
0
Vasoconstrictor Agents
0
Dinoprost
B7IN85G1HY
Dinoprostone
K7Q1JQR04M
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2568-2578Informations de copyright
© 2019 Federation of American Societies for Experimental Biology.
Références
Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999;79:1193-1226.
Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000;69:145-182.
Sugimoto Y, Narumiya S. Prostaglandin E receptors. J Biol Chem. 2007;282:11613-11617.
Namba T, Sugimoto Y, Negishi M, et al. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature. 1993;365:166-170.
Watabe A, Sugimoto Y, Honda A, et al. Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. J Biol Chem. 1993;268:20175-20178.
Kennedy CR, Zhang Y, Brandon S, et al. Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat Med. 1999;5:217-220.
Audoly LP, Tilley SL, Goulet J, et al. Identification of specific EP receptors responsible for the hemodynamic effects of PGE2. Am J Physiol. 1999;277:H924-H930.
Chen L, Miao Y, Zhang Y, et al. Inactivation of the E-prostanoid 3 receptor attenuates the angiotensin II pressor response via decreasing arterial contractility. Arterioscler Thromb Vasc Biol. 2012;32:3024-3032.
Armstrong JM, Boura AL, Hamberg M, Samuelsson B. A comparison of the vasodepressor effects of the cyclic effects of the cyclic endoperoxides PGG, and PGH2 with those of PGD2 and PGE2 in hypertensive and normotensive rats. Eur J Pharmacol. 1976;39:251-258.
Nasjletti A. Arthur C. Corcoran memorial lecture. The role of eicosanoids in angiotensin-dependent hypertension. Hypertension. 1998;31:194-200.
Martineau A, Robillard M, Falardeau P. Defective synthesis of vasodilator prostaglandins in the spontaneously hypertensive rat. Hypertension. 1984;6:I161-165.
Tan SY, Sweet P, Mulrow PJ. Impaired renal production of prostaglandin E2: a newly identified lesion in human essential hypertension. Prostaglandins. 1978;15:139-150.
Audoly LP, Ruan X, Wagner VA, et al. Role of EP(2) and EP(3) PGE(2) receptors in control of murine renal hemodynamics. Am J Physiol Heart Circ Physiol. 2001;280:H327-H333.
Ishida K, Matsumoto T, Taguchi K, Kamata K, Kobayashi T. Protein kinase C delta contributes to increase in EP3 agonist-induced contraction in mesenteric arteries from type 2 diabetic Goto-Kakizaki rats. Pflugers Arch. 2012;463:593-602.
Kida T, Sawada K, Kobayashi K, Hori M, Ozaki H, Murata T. Diverse effects of prostaglandin E(2) on vascular contractility. Heart Vessels. 2014;29:390-395.
Longrois D, Gomez I, Foudi N, et al. Prostaglandin E(2) induced contraction of human intercostal arteries is mediated by the EP(3) receptor. Eur J Pharmacol. 2012;681:55-59.
Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM, Feletou M. Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. Br J Pharmacol. 2005;146:834-845.
Tang EH, Jensen BL, Skott O, et al. The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats. Cardiovasc Res. 2008;78:130-138.
Li Z, Zhang Y, Liu B, Luo W, Li H, Zhou Y. Role of E-type prostaglandin receptor EP3 in the vasoconstrictor activity evoked by prostacyclin in thromboxane-prostanoid receptor deficient mice. Sci Rep. 2017;7:42167.
Liu B, Li J, Yan H, et al. TP and EP3 receptors mediate the vasoconstrictor and pressor responses of prostaglandin F2a in mice and/or humans. FASEB J. 2019;33:2451-2459.
Dunn MJ, Grone HJ. The relevance of prostaglandins in human hypertension. Adv Prostaglandin Thromboxane Leukot Res. 1985;13:179-187.
Jin J, Tang Q, Li Z, et al. Prostaglandin E2 regulates renal function in C57/BL6 mouse with 5/6 nephrectomy. Life Sci. 2017;174:68-76.
McGiff JC, Malik KU, Terragno NA. Prostaglandins as determinants of vascular reactivity. Fed Proc. 1976;35:2382-2387.
Purdy KE, Arendshorst WJ. EP(1) and EP(4) receptors mediate prostaglandin E(2) actions in the microcirculation of rat kidney. Am J Physiol Renal Physiol. 2000;279:F755-F764.
Eskildsen MP, Hansen PB, Stubbe J, et al. Prostaglandin I2 and prostaglandin E2 modulate human intrarenal artery contractility through prostaglandin E2-EP4, prostacyclin-IP, and thromboxane A2-TP receptors. Hypertension. 2014;64:551-556.
Baer PG, Navar LG. Renal vasodilation and uncoupling of blood flow and filtration rate autoregulation. Kidney Int. 1973;4:12-21.
van Rodijnen WF, Korstjens IJ, Legerstee N, Ter Wee PM, Tangelder GJ. Direct vasoconstrictor effect of prostaglandin E2 on renal interlobular arteries: role of the EP3 receptor. Am J Physiol Renal Physiol. 2007;292:F1094-F1101.
Inscho EW, Carmines PK, Navar LG. Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists. Am J Physiol. 1990;259:F157-F163.
Hockel GM, Cowley AW Jr. Effect of chronic intrarenal prostaglandin E2 infusion and angiotensin II blockade on arterial pressure in the dog. Adv Prostaglandin Thromboxane Res. 1980;7:1061-1065.
Hockel GM, Cowley AW Jr. Role of the renin-angiotensin system in prostaglandin E2-induced hypertension. Hypertension. 1980;2:529-537.
Liu B, Luo W, Zhang Y, et al. Role of cyclooxygenase-1-mediated prostacyclin synthesis in endothelium-dependent vasoconstrictor activity of porcine interlobular renal arteries. Am J Physiol Renal Physiol. 2012;302:F1133-F1140.
Liu B, Zhang Y, Zhu N, Li H, Luo W, Zhou Y. A vasoconstrictor role for cyclooxygenase-1-mediated prostacyclin synthesis in mouse renal arteries. Am J Physiol Renal Physiol. 2013;305:F1315-F1322.
Luo W, Liu B, Zhou Y. The endothelial cyclooxygenase pathway: Insights from mouse arteries. Eur J Pharmacol. 2016;780:148-158.
Vanhoutte PM. Endothelium-dependent contractions in hypertension: when prostacyclin becomes ugly. Hypertension. 2011;57:526-531.
Liu B, Zhan M, Zhang Y, et al. Increased role of E prostanoid receptor-3 in prostacyclin-evoked contractile activity of spontaneously hypertensive rat mesenteric resistance arteries. Sci Rep. 2017;7:8927.
Zhu N, Liu B, Luo W, et al. Vasoconstrictor role of cyclooxygenase-1-mediated prostacyclin synthesis in non-insulin-dependent diabetic mice induced by high-fat diet and streptozotocin. Am J Physiol Heart Circ Physiol. 2014;307:H319-H327.
Hu C, Liu B, Xu Y, et al. EP3 blockade adds to the effect of TP deficiency in alleviating endothelial dysfunction in atherosclerotic mouse aortas. Front Physiol. 2019;10:1247.
Zhou Y, Varadharaj S, Zhao X, Parinandi N, Flavahan NA, Zweier JL. Acetylcholine causes endothelium-dependent contraction of mouse arteries. Am J Physiol Heart Circ Physiol. 2005;289:H1027-H1032.
Liu B, Luo W, Zhang Y, et al. Involvement of cyclo-oxygenase-1-mediated prostacyclin synthesis in the vasoconstrictor activity evoked by ACh in mouse arteries. Exp Physiol. 2012;97:277-289.
Li S, Liu B, Luo W, et al. Role of cyclooxygenase-1 and -2 in endothelium-dependent contraction of atherosclerotic mouse abdominal aortas. Clin Exp Pharmacol Physiol. 2016;43:67-74.
Hristovska AM, Rasmussen LE, Hansen PB, et al. Prostaglandin E2 induces vascular relaxation by E-prostanoid 4 receptor-mediated activation of endothelial nitric oxide synthase. Hypertension. 2007;50:525-530.
Thibodeau JF, Holterman CE, He Y, et al. Vascular smooth muscle-specific EP4 receptor deletion in mice exacerbates angiotensin ii-induced renal injury. Antioxid Redox Signal. 2010;25:642-656.
Schweda F, Klar J, Narumiya S, Nusing RM, Kurtz A. Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys. Am J Physiol Renal Physiol. 2004;287:F427-F433.
Rifkind JM, Berkowitz DE, Mohanty JG. Regulation of vascular function by circulating blood. Front Physiol. 2019;10:492.